Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment-Reference-Cited by-同舟云学术

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment

Published:2024-04 Issue:4 Volume:211 Page:533-538
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Holzbeierlein Jeffrey M.¹,Bixler Brooke R.²,Buckley David I.³,Chang Sam S.⁴,Holmes Rebecca³,James Andrew C.⁵,Kirkby Erin²,McKiernan James M.⁶,Schuckman Anne K.⁷

Affiliation:

1. Department of Urology, University of Kansas Cancer Center, Kansas City, Kansas

2. American Urological Association, Linthicum, Maryland

3. Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland, Oregon

4. Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee

5. Department of Urology, Texas Urology Group, San Antonio, Texas

6. Department of Urology, University of Columbia, New York, New York

7. Department of Urology, University of Southern California Urological Oncology, Los Angeles, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003846

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Faith and a sunny day”: Association of patient frailty with strain experienced by informal caregivers of older adults with non-muscle-invasive bladder cancer;Journal of Geriatric Oncology;2024-11

2. Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer;Radiology;2024-09-01

3. An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2024-09

4. Bladder cancer: non-coding RNAs and exosomal non-coding RNAs;Functional & Integrative Genomics;2024-08-31

5. Recent Advances in Drug Delivery Strategies for High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Brief Review from 2018 to 2024;Pharmaceutics;2024-08-30